Efficacy of Dapagliflozin in Diabetes Associated Peripheral Neuropathy

NCT05162690 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Peripheral Neuropathy

Interventions

DRUG: Dapagliflozin 10 milligram
OTHER: Placebo

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh